Post-COVID, chest pains may linger for up to a year, new study finds Roshni Dhar9 March 2023 5:47 PM ISTEven patients with mild COVID-19 infections can suffer from health complications for months, even years, post infection. Nearly 19% of U.S. adults who...
Health Bulletin 9/March/2023 Roshni Dhar9 March 2023 4:11 PM ISTHere are the top health stories for the day:900 NEET SS seats still vacant: Doctors demand another Mop-Up RoundPointing out that more than 900...
Way Indian pharma sector gained trust during COVID was unprecedented: PM Narendra Modi Ruchika Sharma6 March 2023 5:06 PM IST"We wish to provide timely healthcare to all citizens through digital health ID system," PM Modi said.
COVID ends but illness remains: Demystifying Post COVID symptoms with Dr Suresh Kumar, LNJP Hospital MD Bureau4 March 2023 5:22 PM ISTIn recent years the world has experienced a catastrophe called COVID and after numerous attempts, the world's nations have managed to contain it. Now,...
Pfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma2 March 2023 4:15 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use...
Medical Bulletin 27/February/2023 Isra Zaman27 Feb 2023 3:00 PM ISTHere are the top medical news for the day:Too little sodium can be bad for heart failure patients, finds studyHeart failure, in which the heart muscle...
EU drug regulator advices against market nod for Merck COVID pill Lagevrio for adults Ruchika Sharma26 Feb 2023 3:45 PM ISTUS: The European Union's drug regulator said on Friday its Committee for Medicinal Products for Human Use has advised against market authorisation of...
Pfizer, BioNTech seek USFDA nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine for ages 12 years and older as primary series or booster Ruchika Sharma25 Feb 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that they have submitted a supplemental Biologics License Application (sBLA) to the U.S....
Personalized aerobic and strength training program Improves Long COVID Symptoms Dr. Kamal Kant Kohli24 Feb 2023 8:00 PM ISTResearchers at University of Murcia, Spain found in a new study that a supervised, eight-week exercise program improved symptoms of patients with long...
LAGEVRI did not demonstrate statistically significant reduction in COVID risk following household exposure to another individual with COVID: Merck Ruchika Sharma23 Feb 2023 9:00 AM ISTRahway: Merck, known as MSD outside the United States and Canada, has announced that LAGEVRI (molnupiravir) did not demonstrate a statistically...
Study finds COVID-19 vaccination linked to fewer cardiac events Isra Zaman22 Feb 2023 10:00 AM ISTResearchers from the Icahn School of Medicine at Mount Sinai have revealed that vaccination against COVID-19 is associated with fewer heart attacks,...
Moderna gets Health Canada authorization for Omicron-targeting bivalent COVID booster vaccine for 6 to 17 years old Ruchika Sharma19 Feb 2023 1:00 PM ISTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that Health Canada has...
